Evaluation of Plasma Human Herpesvirus 8 DNA as a Marker of Clinical Outcomes during Antiretroviral Therapy for AIDS‐Related Kaposi Sarcoma in Zimbabwe-Reference-Cited by-同舟云学术

Evaluation of Plasma Human Herpesvirus 8 DNA as a Marker of Clinical Outcomes during Antiretroviral Therapy for AIDS‐Related Kaposi Sarcoma in Zimbabwe

Published:2010-08 Issue:3 Volume:51 Page:342-349
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:CLIN INFECT DIS

Author:

Borok Margaret,Fiorillo Suzanne,Gudza Ivy,Putnam Beverly,Ndemera Buxton,White Irene E.,Gwanzura Lovemore,Schooley Robert T.,Campbell Thomas B.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/51/3/342/875517/51-3-342.pdf

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical Significance of Elevated KSHV Viral Load in HIV-Related Kaposi’s Sarcoma Patients in South Africa;Viruses;2024-01-26

2. Evaluation of human herpesvirus‐8 viremia and antibody positivity in patients with HIV infection with human herpesvirus‐8‐related diseases;Journal of Medical Virology;2023-12

3. Predictive Value of Serum Biomarkers for Response of Limited-Stage AIDS-Associated Kaposi Sarcoma to Antiretroviral Therapy With or Without Concomitant Chemotherapy in Resource-Limited Settings;JAIDS Journal of Acquired Immune Deficiency Syndromes;2023-10-01

4. Kaposi’s Sarcoma in Children After Hematopoietic Stem Cell Transplantation: Two Cases of Rare Primary Tumor Localizations in the Lungs and Lymph Node;Journal of Pediatric Hematology/Oncology;2023-09-05

5. Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial;PLOS ONE;2023-05-17